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Polychlorinated biphenyls (PCBs) are a
group of structurally diverse and persistent
environmental pollutants, widely distributed
as complex mixtures. Mechanisms of toxicity
of individual PCB congeners depend on the
planarity of a molecule (Safe 1994), as well as
on molecular weight and biotransformation
rate (Rose et al. 2002). Similarly to 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), the
coplanar non-ortho-substituted PCBs activate
aryl hydrocarbon receptor (AhR) and AhR-
dependent signal transduction pathways (van
den Berg et al. 1998). A majority of the
adverse effects of these compounds is thought
to be mediated through AhR activation.
Therefore, the toxic potencies of dioxin-like
PCBs can be expressed in terms of toxic
equivalency factors (TEFs) relative to TCDD
as the reference toxicant. The TEF values of
individual PCBs multiplied by their respective
concentrations can be used to yield TCDD
toxic equivalents (TEQs) (van den Berg et al.
1998). In contrast, a distinct set of AhR-inde-
pendent effects, including neurotoxicity,
(anti)estrogenicity, and tumor promotion, has
been found after exposure to noncoplanar
ortho-substituted PCBs (Brouwer et al. 1999;
Hansen 1998; Machala et al. 2003; Robertson
and Hansen 2001); however, the modes
of action of nondioxin-like PCBs are often
not clear.
The biological activities of PCBs have been
reported to include both estrogenic and anti-
estrogenic effects in various in vitro and in vivo
models (Cooke et al. 2001; Hansen 1998).
TCDD and other AhR agonists, including
dioxin-like PCBs, have been frequently
reported to have antiestrogenic activity
(Buchanan et al. 2000, 2002; Oenga et al.
2004; Safe and Wörmke 2003). Several modes
of antiestrogenic action of AhR agonists might
include repression of 17β-estradiol (E2)-
dependent gene expression by interactions of
activated AhR with DNA regions of E2
responsive gene promoters (see Oenga et al.
2004, Safe and Wörmke 2003), inhibition of
E2-induced cell cycle proteins and uterine
epithelial mitogenesis (Buchanan et al. 2002;
Wang et al. 1998), or effects of PCBs on E2
metabolism (Pang et al. 1999; van Duursen
et al. 2003). In contrast, the exact mechanisms
of estrogenic or antiestrogenic activities of
nondioxin-like PCBs are still not fully charac-
terized. The reported results are often contra-
dictory, derived from data obtained in
different in vitro or in vivo models (Hansen
1998). The majority of studies found that low-
molecular-weight PCBs elicit estrogenic
activity both in vitro and in vivo (Arcaro et al.
1999; Nesaretnam and Darbre 1997; Rogers
and Denison 2000; Rose et al. 2002). In con-
trast, the three most prevalent nondioxin-like
PCBs, 2,2´,3,4,4´,5´-hexachlorobiphenyl
(PCB 138), 2,2´,4,4´,5,5´-hexachlorobiphenyl
(PCB 153), and 2,2´,3,4,4´,5,5´-heptachloro-
biphenyl (PCB 180), have been reported to be
antiestrogenic in MCF-7 cells (Bonenfeld-
Jorgensen et al. 2001). However, estrogenic/
antiestrogenic potencies of a large set of PCB
congeners have not yet been determined in a
single in vitro bioassay. Taken together, there is
only limited information on effects of preva-
lent nondioxin-like PCBs and complex PCB
mixtures in mammalian blood and tissues.
One essential question is whether the
chronic exposure to low doses of environ-
mental persistent organic pollutants (POPs),
including PCBs, has endocrine-disrupting
effects on exposed human populations
(Brouwer et al. 1999; Daston et al. 2003).
There are only limited data on estrogenic and
dioxin-like activities of complex samples of
organic compounds collected from human
blood. Sonnenschein et al. (1995) and Soto
et al. (1997) reported the development of a
serum extraction method for separation of
POPs and endogenous steroids. Recently, this
extraction and fractionation technique has
been adapted for combined chemical and
in vitro assay analysis in human blood, allow-
ing for discrimination of effects of endogenous
hormones and xenoestrogens (Fernandez et al.
2004). However, results of direct measure-
ments of estrogen receptor (ER)-mediated
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Polychlorinated biphenyls (PCBs) are thought to cause numerous adverse health effects, but their
impact on estrogen signaling is still not fully understood. In the present study, we used the
ER-CALUX bioassay to determine estrogenic/antiestrogenic activities of the prevalent PCB con-
geners and PCB mixtures isolated from human male serum. The samples were collected from resi-
dents of an area with an extensive environmental contamination from a former PCB production
site as well as from a neighboring background region in eastern Slovakia. We found that the lower-
chlorinated PCBs were estrogenic, whereas the prevalent higher-chlorinated PCB congeners 138,
153, 170, 180, 187, 194, 199, and 203, as well as major PCB metabolites, behaved as anti-
estrogens. Coplanar PCBs had no direct effect on estrogen receptor (ER) activation in this in vitro
model. In human male serum samples, high levels of PCBs were associated with a decreased
ER-mediated activity and an increased dioxin-like activity, as determined by the DR-CALUX assay.
17β-Estradiol (E2) was responsible for a major part of estrogenic activity identiﬁed in total serum
extracts. Signiﬁcant negative correlations were found between dioxin-like activity, as well as mRNA
levels of cytochromes P450 1A1 and 1B1 in lymphocytes, and total estrogenic activity. For sample
fractions containing only persistent organic pollutants (POPs), the increased frequency of anti-
estrogenic samples was associated with a higher sum of PCBs. This suggests that the prevalent non-
dioxin-like PCBs were responsible for the weak antiestrogenic activity of some POPs fractions. Our
data also suggest that it might be important to pay attention to direct effects of PCBs on steroid
hormone levels in heavily exposed subjects. Key words: CYP1A1, CYP1B1, dioxin-like activity, estra-
diol, estrogenicity, human serum, polychlorinated biphenyls. Environ Health Perspect 113:1277–1284
(2005). doi:10.1289/ehp.7745 available via http://dx.doi.org/ [Online 26 May 2005]activity of serum extracts or total POPs frac-
tions in a comprehensive set of human subjects
have not yet been published. More informa-
tion is available concerning in vitro bioassays of
dioxin-like activity in human blood contami-
nated with PCBs. The total TEQ values deter-
mined in human female serum and follicular
fluid by the DR-CALUX (dioxin receptor–
chemically activated luciferase expression)
assay have been reported to correlate well
with the sum of four major PCB congeners:
153, 138, 180, and 118 (Pauwels et al. 2000).
The possible impact of environmental
endocrine disruptors on breast cancer, male
reproductive tract problems, or prostate can-
cer is questionable (Chen et al. 2003; Safe
2004). Nevertheless, estrogens play a signiﬁ-
cant role in, for example, testicular function
(O’Donnell et al. 2001). Because the levels of
endogenous estrogens in males are consider-
ably lower than in females, possible estrogenic/
antiestrogenic impact of high levels of
contamination could be more pronounced in
males. Therefore, determination of in vitro
estrogenic/antiestrogenic activities of extracts
of human male blood samples collected from a
PCB-contaminated area could yield more
information about the impact of PCBs and/or
other POPs on estrogen-dependent signaling. 
Since 1959, several thousand tons of
residues from the Chemko Stráz ˇske chemical
plant in the Michalovce district, Slovakia,
have been deposited in the nearby river and
water reservoir sediments. This has resulted in
widespread contamination of the environ-
ment, leading to high human exposure.
Serum PCB concentrations in subjects from
six different districts of Slovakia suggest that
levels are three to six times higher in subjects
from the Michalovce district (Koc ˇan et al.
2001). When serum levels of 15 PCBs were
compared in residents of two districts in east-
ern Slovakia, one with extensive environ-
mental contamination from a former PCB
production site (Michalovce) and the other
matched on geography but with background
PCB levels, the age-adjusted geometric means
for the sum of 15 measured PCB congeners
were statistically significantly higher in sub-
jects from the Michalovce district for both
sexes: 3327.6 versus 1331.4 ng/g lipid in
males, 2751.8 versus 992.2 ng/g lipid in
females (Pavúk et al. 2004).
As a part of a large epidemiologic study,
the PCBRisk project (Trnovec et al. 2000), we
investigated effects of extensive contamination
with PCBs on human serum dioxin-like, estro-
genic, and antiestrogenic activities of serum
extracts from subjects living in the contami-
nated area. In this study, the ER-mediated
activities of individual PCB congeners, which
were identiﬁed as principal contaminants pre-
sent in serum of human population in the
studied area, were investigated using the
T47D breast cancer cell line stably transfected
with the luciferase reporter gene under control
of estrogen-responsive elements, detecting the
direct activation of ER (the ER-CALUX assay)
(Legler et al. 1999). In the second step of the
study, effects of chronic PCB exposure on
antiestrogenic/estrogenic and dioxin-like activ-
ities exerted by extracts of human male sera
(150 human male serum samples) were
assessed and compared to concentrations of
major POPs and levels of E2 in serum.
Materials and Methods
Chemicals. The PCB nomenclature used here
is from the International Union of Pure and
Applied Chemistry (IUPAC). PCBs 74, 156,
170, 187, 199, and 203 were purchased from
Ehrenstorfer (Augsburg, Germany); PCBs 28,
52, 66, 99, 101, 105, 118, 126, 138, 153,
180, and 194 were supplied by Promochem
(Wesel, Germany). Purity of all compounds
was > 99%. The chemical structure and
nomenclature of the PCB congeners we stud-
ied is presented in Figure 1. TCDD was sup-
plied by Cambridge Isotope Laboratories,
(Andover, MA, USA); E2, cell culture media,
and solvents were obtained from Sigma-
Aldrich (Prague, Czech Republic). Stock solu-
tions were prepared with dimethyl sulfoxide
(DMSO) and stored in the dark. The final
concentrations of solvent in the medium did
not exceed 0.2% (vol/vol).
Blood sampling, extraction, and clean up.
We collected 150 individual male blood sam-
ples from residents of two areas of eastern
Slovakia, which are differently contaminated
with PCBs: the Michalovce district, where
commercial PCB mixtures were produced for
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Figure 1. Chemical structures of selected PCB congeners examined for the antiestrogenic/estrogenic activi-
ties in human breast carcinoma T47D.Luc cells (ER-CALUX assay). (A) Lower molecular-weight PCBs present
in low concentrations in male blood samples. (B) Non-ortho-chlorinated PCB. (C) PCB congeners occurring
in relatively higher concentrations in male blood. (D) Prevalent high-molecular-weight PCB congeners.a number of years (Koc ˇan et al. 2001), and the
Stropkov district, which represented the back-
ground area. The samples of human male
serum (5 mL) were treated with 2 mL
methanol and extracted three times with
n-hexane:diethyl ether (1:1); the extracts were
evaporated and dissolved in 1 mL dichloro-
methane (Horander et al. 2004). For deter-
mination of overall ER-mediated activity, we
replaced the solvent with DMSO in one-half
of the crude extract; the second half of the
sample was placed on a sulfuric acid-activated
silica column and eluted with n-hexane:diethyl
ether mixture, evaporated, and redissolved in
DMSO (Murk et al. 1997). Using these
experimental settings, only persistent com-
pounds were eluted, including PCBs and
polychlorinated dibenzo-p-dioxins (PCDDs)
and dibenzofurans (PCDFs).
Chemical analysis of POPs. We deter-
mined concentrations of prevalent (non-
coplanar) PCB congeners, hexachlorobenzene,
and p,p´-DDE by gas chromatography/mass
spectrometry (GC/MS) (Koc ˇan et al. 2001,
2004). We calculated TEQs from high perfor-
mance GC/MS data on blood concentrations
of PCDD/PCDFs and non-ortho- and mono-
ortho-chlorinated PCBs. The sum of PCBs
(ΣPCBs) used in the correlation and multi-
variate statistical analysis was based on the
data on concentrations of 17 indicator copla-
nar and mono-ortho-chlorinated PCB con-
geners, including PCBs 28, 52, 66, 74, 77, 99,
101, 105, 118, 126, 138, 153, 156, 169, 170,
180, and 189.
Determination of effects associated with
AhR activation. We determined the levels of
cytochrome P450 (CYP) 1A1 and CYP1B1
mRNA in human peripheral lymphocytes by
RNA extraction and a quantitative reverse-tran-
scriptase-polymerase chain reaction (RT-PCR)
method using TaqMan technology (Canton
et al. 2003; van Duursen et al. 2005). The
in vitro potencies of POPs present in serum to
activate AhR were measured in sulfuric acid/sil-
ica-treated extracts by a luciferase reporter gene
assay (DR-CALUX; BioDetection Systems,
Amsterdam, the Netherlands) as described pre-
viously (Murk et al. 1996).
ER-mediated activity and determination
of E2 in male blood samples. We determined
estrogenic activities of 17 prevalent PCB con-
geners using the ER-CALUX bioassay
(BioDetection Systems) using the human
breast carcinoma T47D.Luc cell line, stably
transfected with pEREtataLuc construct
(Legler et al. 1999; Machala et al. 2004).
ER-mediated activity was also determined in
the cells treated with either total serum
hexane/diethyl ether extracts or with a fraction
of POPs obtained by a consequent sulfuric
acid/silica fractionation. We determined anti-
estrogenicity as a decrease in response to E2 in
the cells co-treated with the individual PCB or
POPs fraction. Concentrations of E2 were
determined by ELISA (ADVIA Centaur
Estradiol-6 III assay; Bayer HealthCare,
Tarrytown, NY, USA) in 60 samples selected
according to stratiﬁed PCB levels. We deter-
mined cytotoxicity of extracts or individual
PCBs by a neutral red uptake assay after a
24-hr exposure.
Data analyses. All calculations were per-
formed with Microsoft Excel, SlideWritePlus
3.0 for Windows, or Statistica 6.1 for
Windows (Microsoft Corporation, Redmond,
WA, USA). Nonparametric statistical analy-
ses (Kruskal-Wallis analysis of variance and
the Mann-Whitney U test) were used for data
analysis. We determined the relationships
among biological and chemical data by corre-
lation analysis and multivariate principal
component analysis (PCA). We assessed the
correlations among the compared parameters
using nonparametric Spearman’s rank coefﬁ-
cient (Rs). For the PCA analysis, all the data
were normalized using the transformation log
(X + 1).
Results
Estrogenic and antiestrogenic potencies of a
series of individual PCB congeners, found to
be prevalent in the human male blood sam-
ples, were determined in the ER-CALUX
assay. Lower-molecular-weight PCBs 28, 52,
66, and 74 elicited a signiﬁcant ER-mediated
activity at micromolar concentrations.
Pentachlorobiphenyls (PCBs 99 and 105)
were only partial ER agonists (Figure 2A).
The ER activation by its natural ligand E2
was potentiated when cells were co-treated
with trichlorobiphenyls (PCB 28 or 52)
(Figure 2B). The most prevalent PCB con-
geners, 138, 153, 170, 180, and 187, as well
as octachlorobiphenyls (PCBs 194, 199, and
203) did not induce the ER-dependent
luciferase activity (data not shown), but they
all significantly decreased the E2-induced
luciferase activity (Figure 3). The most potent
inhibitors of ER activation were PCBs 199,
203, and 153; however, the IC50 (concentra-
tion that inhibits 50% of maximal E2 response)
values of all tested congeners were within a
Estrogen receptor-mediated activity of PCBs
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Figure 2. Dose-dependent estrogenic effect of the individual PCB congeners (A) and the combined effect
of two estrogenic PCB congeners (PCBs 28 and 52) plus 3 pM E2 (B) on induction of luciferase activity in
the ER-CALUX assay. Results are expressed as mean ± SD.
*p < 0.05, and **p < 0.01 compared with control. 
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Figure 3. Dose-dependent effect of four indicator PCB congeners (A) and six higher chlorinated PCBs (B) on
3 pM E2-induced luciferase activity in T47D.Luc cells. Results are expressed as mean ± SD.narrow concentration range, 2.9–16.0 µM. A
partially reconstituted mixture of the most
prevalent PCBs, reflecting a typical ratio of
concentrations of individual congeners,
showed a significantly higher antiestrogenic
activity when compared with inhibition
potency of PCB 153 (Figure 4). Potent AhR
agonists (dioxin-like PCBs 126, 118, 105, and
156) did not signiﬁcantly affect the ER activa-
tion in the ER-CALUX assay. The estrogenic
and antiestrogenic effects of PCB congeners,
including the data on their cytotoxicity and
calculated median effective concentration
(EC50) values, are summarized in Table 1.
In the second step of this study, we deter-
mined the estrogenic activities of 150 human
male serum samples, collected in Michalovce
and Stropkov districts, Slovakia, using the
ER-CALUX bioassay. The total hexane/
diethyl ether extracts of human male serum
samples, containing both endogenous steroids
and POPs, showed significant estrogenic
responses in the ER-CALUX assay, ranging
from 12.5 to 59.2 pg E2 equivalents (EEQ)
per milliliter (Table 2). Dioxin-like activities,
measured in the POPs fractions by the
DR-CALUX bioassay, ranged from 0.2 to
2.9 pg TEQs/mL (Table 2). Weak estrogenic
or antiestrogenic activities were found in the
fractions of POPs, but only in part of the sam-
ples. The POPs fractions from the less pol-
luted background area elicited ER-mediated
activity with a higher incidence (18 of 75 sam-
ples vs. 8 of 75 samples), whereas anti-
estrogenic activity was detected more
frequently in the samples from the PCB-
polluted region (5 and 17 samples, respec-
tively). However, the ER-mediated activities
did not overcome 2 pg EEQs/mL, and only
partial estrogenic or antiestrogenic responses
(< 40%) were found in positive samples (data
not shown). Conversion of concentration
units showed that only submicromolar con-
centrations of prevalent PCBs were present in
cultivation medium when serum extracts were
applied to cells (data not shown); therefore,
only partial antiestrogenic effects of PCBs
could be expected in the sample mixtures.
The in vitro bioassay data were compared
with data on concentrations of major POPs in
the samples obtained in the PCBRisk project.
In this large epidemiological study, > 2,000
human blood samples were evaluated for con-
centrations of PCBs, PCDD/PCDFs, and
p,p´-DDE (Koc ˇan et al. 2004). The analytical
data for the subset of 150 male samples,
which were used here for statistical analysis of
in vitro bioassay data only, are summarized in
Table 2. Additionally, data on induction of
AhR-dependent expression of CYP1A1 and
CYP1B1 mRNA in blood lymphocytes, as
determined by real-time PCR (Canton et al.
2003; van Duursen et al. 2005), and E2 con-
centration determined in a substantial part of
blood sample extracts were included in the
statistical analysis. PCDDs did not contribute
significantly to higher levels of TEQs, and
concentrations of PCDFs, which might also
contribute to the dioxin-like activities, were
only marginally increased in highly exposed
male subjects (Koc ˇan et al. 2004). High con-
centrations of p,p´-DDE were found in a
majority of samples (Table 2); however, only
weak estrogenic and no dioxin-like activity
was found for this compound (data not
shown). Therefore, modulations of biological
effects might be attributed mainly to differ-
ences in the concentrations of PCBs. 
Total estrogenic activity was moderately
decreased, while the dioxin-like activity was
increased, in samples with high PCB levels
ranging from 13.9 to 175.5 ng/mL serum
Plís ˇková et al.
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Figure 4. Antiestrogenic potencies of PCB 153 and
an artificial mixture of the most prevalent PCBs
(ratio of 6:3:5:2 of PCBs 153, 138, 170, and 180).
Results are expressed as mean ± SD. 
*p < 0.05 compared with an equimolar concentration of
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Table 1. PCB congeners under study, including molecular weights and estrogenic/antiestrogenic and
cytotoxic effects determined in ER-CALUX assay using human breast carcinoma T47D.Luc cells.
PCB ER-activated activity Antiestrogenicity Cytotoxicity
(IUPAC) Structure IECa (µM) IEFb IC50
c(µM) IhEFd LOECe (µM)
28 2,4,4´-Trichlorobiphenyl 8.23 1.65 × 10–7 NI NI > 20
52 2,2´,5,5´-Tetrachlorobiphenyl 9.52 1.42 × 10–7 NI NI > 20
66 2,3´,4,4´-Tetrachlorobiphenyl 24.31 8.56  × 10–8 NI NI > 40
74 2,4,4´,5-Tetrachlorobiphenyl 17.00 1.24  × 10–7 NI NI > 40
99 2,2´,4,4´,5-Pentachlorobiphenyl WI WI NI NI > 40
105 2,3,3´,4,4´-Pentachlorobiphenyl WI WI NI NI > 40
118 2,3´,4,4´,5-Pentachlorobiphenyl NI NI NI NI > 20
126 3,3´,4,4´,5-Pentachlorobiphenyl NI NI NI NI > 40
138 2,2´,3,4,4´,5´-Hexachlorobiphenyl NI NI 10.12 4.94 × 10–6 20
153 2,2´,4,4´,5,5´-Hexachlorobiphenyl NI NI 5.89 8.50 × 10–6 20
156 2,3,3´,4,4´,5-Hexachlorobiphenyl NI NI WI WI 40
170 2,2´,3,3´,4,4´,5-Heptachlorobiphenyl NI NI 16.03 3.12 × 10–6 25
180 2,2´,3,4,4´,5,5´-Heptachlorobiphenyl NI NI 9.32 5.36 × 10–6 20
187 2,2´,3,4´,5,5´,6-Heptachlorobiphenyl NI NI 7.48 6.68 × 10–6 20
194 2,2´,3,3´,4,4´,5,5´-Octachlorobiphenyl NI NI 14.14 3.54 × 10–6 25
199 2,2´,3,3´,4´,5,6,6´-Octachlorobiphenyl NI NI 2.85 1.75 × 10–5 20
203 2,2´,3,4,4´,5,5´,6-Octachlorobiphenyl NI NI 3.20 1.56 × 10–5 20
Abbreviations: IEC, induction equivalency concentration; IEF, induction equivalency factor; IhEF, inhibitory equivalency fac-
tor; NI, no significant induction/inhibition; WI, weak induction/inhibition (< 50% of estradiol maximum induction; < 50%
decrease in induction of 3 pM E2).
aConcentration of PCB congener inducing the same level of luciferase activity as the EC50 of the reference inducer E2
(2.08 pM). bCalculated as the ratio between the EC50 of E2 and the concentration of the selected PCB congener inducing
the same level of luciferase activity. cConcentration of PCB congener causing 50% decrease in luciferase activity induced
by 3 pM E2. dCalculated as the ratio between the IC50 of the synthetic antiestrogen ICI 182,780 (IC50 = 50 pM) and the con-
centration of the selected PCB congener causing the same level of decrease in luciferase activity induced by 3 pM E2.
eLowest (experimental) concentration of PCB congener causing a significant decrease of cell viability (24-hr exposure
Neutral Red uptake assay).
Table 2. Summary of data from human male serum samples used in multivariate statistical analysis.
Concentration/mL serum Concentration/g lipid
No. Range Median Mean Range Median Mean
Estrogenic activity 150 12.5–59.2 28.2 29.2 1.3–11.6 4.1 4.3
(pg EEQs)
E2 (pg) 60 < 1.0–43.5 15.5 15.8 0.1–5.4 2.0 2.1
Dioxin-like activity 144 0.2–2.9 0.6 0.7 11.9–434.0 83.6 92.0
(pg TEQs)
ΣPCBs/PCDD/PCDFs 100 0.05–0.5 0.1 0.2 7.5–57.9 18.2 20.8
(pg TEQs)
ΣPCBs (µg) 150 0.0020–0.1755 0.0078 0.0147 0.3458–32.51 1.124 2.040
p,p´-DDE (µg) 150 0.0017–0.1165 0.0119 0.0171 0.2689–11.16 1.800 2.219
Sum of PCDD/PCDFs and dioxin-like PCBs was calculated as TEQs according to World Health Organization TEF values
(van den Berg et al. 1998). (i.e., 1865.7–32509.4 ng/g lipid; Figure 5).
Quartiles presented in Figure 5 are based on
concentrations expressed per milliliter of
serum. The alternative data set (expressed on
a gravimetric basis) showed a very similar pat-
tern of effects. The levels of E2 decreased in
the fourth quartile of PCB concentrations,
but the decrease was not signiﬁcant.
Based on concentration data summarized
in Table 2, we performed multivariate PCA to
more precisely characterize statistical associa-
tions between in vitro bioassay data and levels
of major organic contaminants in the blood.
The PCA is one of a set of ordination tech-
niques used in data reduction and summari-
zation. As shown in Figure 6A, the first two
components explained 55% of the variability
of the original data. The axes were aligned
with the directions of greatest variation in
the data set. The other components were
neglected because they did not contribute sig-
niﬁcantly to the meaningful interpretation of
the relationships among biological and chemi-
cal parameters. The ﬁrst principal component
axis represented the chemical variables of the
male serum extracts, such as ΣPCBs, PCB 153
concentration, p,p´-DDE content, and the
biological variable AhR-mediated activity
(DR-CALUX assay). The second principal
component was associated with the ER-medi-
ated activity of serum extracts (ER-CALUX
assay), E2 concentrations, and CYP1A1 and
CYP1B1 mRNA expression level. The length
and direction of the lines represent the signiﬁ-
cance of the associated variables. The PCA
conﬁrmed a positive relation between overall
estrogenicity (12.5–59.2 pg EEQ/ml) and E2
levels (1.0–43.5 pg/ml; Table 2). Further, weak
negative relations between ER-mediated activity
and expression of CYP1A1 and CYP1B1
mRNAs and between estrogenic and dioxin-
like activities were observed (Figure 6A). The
associations of the variables were conﬁrmed by
bivariate rank correlations computed on origi-
nal untransformed data. The estrogenic activ-
ity of serum extracts correlated with E2
concentrations (Rs = 0.510, p < 0.001). Weak
but statistically signiﬁcant negative correlation
between ER-mediated activity and levels of
CYP1A1 mRNA (Rs = –0.241, p < 0.05), as
well as between E2 concentrations and dioxin-
like activity (Rs = –0.227, p < 0.1), were
revealed. No correlation was found between
E2 concentrations and total PCB levels
(Rs = 0.078).
The PCA for the fractions of persistent
compounds explained 60% of the total vari-
ability in the data set (Figure 6B). The first
principal component was associated with a
number of fractions with antiestrogenic
activity (anti-ER), ΣPCBs, PCB 153 content,
and AhR-mediated activity (DR-CALUX
assay). The second principal component axis
represented only the estrogenic activity of
fractions (ER). PCA analysis showed that anti-
estrogenic activity of fractions depended on the
concentrations of PCB congeners and TCDD
equivalents obtained in the DR-CALUX assay
(Rs = 0.246–0.275, p < 0.01). 
Discussion
PCBs have been reported to be both estro-
genic and antiestrogenic, based on various
in vitro and in vivo models. Lower-molecular-
weight PCBs are reportedly estrogenic, with
the exception of dioxin-like 3,3´,4,4´-tetra-
chlorobiphenyl (PCB 77), which elicited anti-
estrogenicity in vivo and also in some in vitro
models (Ramamoorthy et al. 1999).
2,2´,6,6´-Tetrachlorobiphenyl (PCB 54), a
fully ortho-substituted compound not occur-
ring in the environment at significant levels
(Hansen 1998), was estrogenic both in the
MCF-7 cell focus assay and in the rat
uterotrophic assay (Arcaro et al. 1999).
3,3´,5,5´-Tetrachlorobiphenyl (PCB 80),
another model congener, was a weak ER ago-
nist both in vivo and in vitro, while, surpris-
ingly, PCB 52 was inactive in the same models
(Nesaretnam and Darbre 1997). PCB 66 and
PCB 95 (2,2´,3,5´,6-pentachlorobiphenyl)
have been reported to be estrogenic in
BG1LucE2 cells at 10 µM concentrations,
whereas coplanar PCB 77 elicited no ER-
mediated activity in this cellular model (Rogers
and Denison 2000). PCB 52 and PCB 77
caused a modest transient uterotrophic effect
in weaning rats (Rose et al. 2002); however,
PCB 77 attenuated the increase in uterine
weight and cell proliferation in another study
(Jansen et al. 1993). The uterotrophic effects
after exposure to less persistent PCB congeners
showed nonlinear dose responses, and they
decreased rapidly (Rose et al. 2002). However,
all the above data have been obtained from
various models and assays, and estrogenic/
antiestrogenic effects of both lower chlori-
nated and higher chlorinated PCBs present in
the environment have not yet been examined
systematically in one assay. 
In our study, PCBs 28, 52, 66, 74, 99
and 105, all found at signiﬁcant levels in male
serum samples, induced the ER-mediated
activity at micromolar concentrations
Estrogen receptor-mediated activity of PCBs
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be one of the potential modes of action of
low-molecular-weight PCBs. However, the
decrease of total estrogenic activity and E2 lev-
els observed in human serum samples of males
exposed to high PCB levels (Figure 5A) indi-
cated that PCB mixtures elicited an overall
antiestrogenic effect. Therefore, the ER-medi-
ated activity of lower-chlorinated PCBs
appears to have only a limited toxicologic sig-
niﬁcance, perhaps with the exception of acute
transient exposure to PCBs (Rose et al. 2002).
Unlike low-molecular-weight PCBs, the
dioxin-like and prevalent high-molecular-
weight PCB congeners are considered to be
antiestrogenic. TCDD, a model toxicant for
dioxin-like PCBs, exhibits potent anti-
estrogenic activity (Buchanan et al. 2000,
2002; Cooke et al. 2001; Safe and Wörmke
2003). TCDD has little effect on total ER lev-
els (Gierthy et al. 1996), and no direct binding
to ER has been reported (see Safe and Wörmke
2003). Recently, inhibition of ER-mediated
cell proliferation by coplanar PCBs has been
reported in breast cancer cell lines (Oenga et al.
2004). TCDD or coplanar PCBs did not
inhibit E2-induced activity of a reporter con-
struct containing the promoter insert from cre-
atine kinase B in T47D cells, while dioxin-like
compounds, including PCB 77 and PCB 126,
prevented activation of other reporter con-
structs in both MCF-7 and T47D cells,
although only at levels as high as 10 µM
(Ramamoorthy et al. 1999). This suggests that
a type of reporter construct can affect detection
of antiestrogenic activity. One possible mecha-
nism of antiestrogenic activity of AhR ligands
is the direct inhibition of E2-responsive genes
through binding to inhibitory dioxin respon-
sive elements (iDRE) in their promoter
regions. Functional iDREs have been identi-
ﬁed in promoter regions of pS2, c-fos, Hsp27
and cathepsin D genes (reviewed by Safe and
Wörmke 2003). In the present study, anti-
estrogenicity was not elicited by coplanar PCB
126 (Table 1) in the T47D.Luc cells used in
the ER-CALUX assay. The lack of anti-
estrogenic activity of coplanar PCBs observed
in the T47D.Luc cell line might be explained
by the missing iDREs in the reporter con-
struct, which contains three tandem repeats of
the consensus estrogen-responsive element
(ERE) oligonucleotide (Legler et al. 1999). 
On the other hand, this cellular model
allowed us to investigate a direct activation of
ER and/or perturbation of E2-induced ER acti-
vation. While the low-molecular-weight PCBs
elicited ER activation and ER-dependent gene
expression, prevalent and more persistent
high-molecular-weight PCB congeners were
antiestrogenic (Table 1, Figures 3 and 4).
Pulses of exposure to more labile mixtures of
lower chlorinated PCBs may contribute to
transient endocrine disruption, including an
increase in estrogenic activity (Hansen 1998;
Rose et al. 2002). PCB 153 was estrogenic in
the acute 2-day immature rat uterine weight
assay, albeit at very high concentrations (Li
et al. 1994). Antiestrogenic effects of three
prevalent congeners (PCBs 138, 153, and 180)
have been found both in a reporter gene and
cell proliferation MCF-7 assays (Bonenfeld-
Jorgensen et al. 2001). This is in accordance
with our data on antiestrogenicity of high-
molecular-weight PCBs in the ER-CALUX
assay (Table 1). Inhibition of ER activation by
hexa-, hepta- and octachlorinated biphenyls
and suppression of estrogenic signaling found
in serum of males chronically exposed to
PCBs (Figures 3–5) suggest that PCB 153 and
other prevalent congeners could contribute to
overall antiestrogenic response. Contribution
of hydroxy- and methylsulfonyl-PCB metabo-
lites, p,p´-DDE and methylsulfonyl-p,p´-DDE
metabolites to antiestrogenic activities of
POPs might also be of importance. Because
both low- and high-molecular-weight PCBs
and POPs metabolites elicited their effects on
estrogenic activity at similar micromolar con-
centrations (Bonenfeld-Jorgensen et al. 2001;
Letcher et al. 2002; Machala et al. 2004; this
study), it might be expected that the anti-
estrogenic effects of prevalent higher chlori-
nated PCBs would prevail in human male
blood. Nevertheless, antiestrogenic effects of
PCBs detected in human male serum appeared
to be less important, when compared with the
levels of E2, the major contributor of the over-
all estrogenic activity.
In vitro bioassays are a suitable tool for
exposure assessment of dioxin-like and
(anti)estrogenic compounds (van den Berg
et al. 1998; Zacharewski 1997). However,
currently only limited data are available on
dioxin-like activities found in human female
serum and follicular fluid; the TEQs deter-
mined by the DR-CALUX assay have been
reported to correlate well with the sum of
four major PCB congeners 153, 138, 180,
and 118 (Pauwels et al. 2000). The data on
the ER-mediated activity in human blood
samples are still limited. Rasmussen et al.
(2003) reported estrogenic activity in female
serum by E-Screen assay, however, they did
not observe any correlation between estro-
genicity and concentrations of individual
endocrine disruptors. In the present study, a
decrease of total estrogenic activity and
increased dioxin-like activity were found in
serum samples from human males chronically
exposed to PCBs. However, as shown in
Figure 5, correlations with PCB concentra-
tions were significant only in subjects with
high exposure levels.
Our data suggest that exposure to high
levels of PCBs might affect E2 blood levels,
although this was not significant. Currently,
there is little information available about a
possible modulation of steroid hormone levels
after exposure to PCBs. In a recently pub-
lished study, a weak but significant negative
correlation was found between serum levels of
the prevalent PCB 153 congener and testos-
terone in young men, and E2 concentrations
(within a concentration range of 43–144 pM)
were also slightly decreased in the more
exposed subjects (Richthoff et al. 2003). The
concentrations of PCB 153 (23–250 ng/g
lipid) found in these subjects were signifi-
cantly lower that those observed both in the
present study and in previous studies in east-
ern Slovakia (Koc ˇan et al. 2001, 2004). The
concentrations of PCB 153 ranged from 115
to 8,631 ng/g lipid in 150 Slovak male serum
samples included in the present study.
Another experimental study in rats exposed to
PCB mixtures also reported lower testos-
terone and E2 serum levels and suppression of
Plís ˇková et al.
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Figure 7. Potential mechanisms of antiestrogenic effects of coplanar and noncoplanar PCBs. 
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Decreased E2 concentrations could be associ-
ated with AhR activation by dioxin-like
PCBs, leading to enhanced CYP1A/CYP1B1-
catalyzed metabolism of E2 (Gierthy et al.
1996; Spink et al. 1990). Induction of
CYP1A1 and CYP1B1 mRNAs in lympho-
cytes is considered to reflect increased expo-
sure to dioxin-like compounds (Canton et al.
2003; Hanaoka et al. 2002). Within the epi-
demiologic study, Canton et al. (2004) found
increased levels of CYP1A1 and CYP1B1
mRNA only in lymphocytes of males exposed
to very high levels of PCBs (fourth quartile).
This finding suggests that a physiologically
significant AhR-dependent induction of E2-
metabolizing CYP enzymes might occur in
liver and other target tissues. 
Besides CYP1A1, 1A2, and 1B1 iso-
enzymes, CYP3A4 has been suggested to play
a major role in hydroxylation of E2 (Badawi
et al. 2000; Hayes et al. 1996; Pang et al.
1999; Spink et al. 1990; Takemoto et al.
2004; Yamazaki et al. 1998). Induction of
CYP3A4 is a consequence of exposure to
prevalent nondioxin-like PCBs (Gillette et al.
2002; Parkinson et al. 1981). Therefore, both
coplanar and noncoplanar PCBs could
increase E2 metabolism and reduce blood E2
concentrations.
Both dioxin-like and nondioxin-like
PCBs might affect estrogen signaling by mul-
tiple mechanisms, as summarized in Figure 7.
Obviously, this list of modes of action is not
complete; PCBs might also potentially disrupt
the pathways associated with the perturbation
of hypothalamus–pituitary–gonadal axis hor-
mone signaling and steroidogenesis, as
another potential mechanism of E2 modula-
tions by PCBs. 
As outlined in the recent review by Safe
(2004), it is currently not possible to directly
attribute increased incidence of breast cancer
or disorders of the male reproductive tract, for
example, to endocrine disruption associated
with organochlorine exposure. A number of
adverse impacts of high PCB contamination
have been identiﬁed, including perturbations
of thyroid function, immunity, or neuro-
developmental processes (Robertson and
Hansen 2001). However, it was not possible
to associate any of the adverse effects observed
within the frames of the PCBRisk project with
antiestrogenicity of PCBs.
In summary, significant associations
between exposure to PCBs and overall
(anti)estrogenic and dioxin-like activities in the
present study were found only at high exposure
levels. Although the prevalent noncoplanar
PCBs elicited antiestrogenicity in the
ER-CALUX assay, when tested as individual
compounds or as a partially reconstituted mix-
ture, a signiﬁcant estrogenic activity was deter-
mined in whole-serum extracts. Moreover,
only weak or negligible anti/estrogenic activi-
ties were found in serum extract fractions con-
taining exclusively POPs including PCBs. Due
to the presence of E2 in human male blood
and its dominant role in total estrogenic activ-
ity of serum samples, reduction of E2 levels
might be a more significant antiestrogenic
effect of high PCB exposure. This mode of
action, associated with induction of CYP1A1,
CYP1A2, CYP1B1 and/or CYP3A4 enzymes
or perturbation of steroidogenesis and
endocrine signaling, preceding the biosynthesis
of estrogens, deserves further attention.
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